These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5808493)

  • 41. [Biochemical principles of diet therapy].
    Pokrovskiĭ AA
    Vopr Pitan; 1969; 28(1):3-10. PubMed ID: 4903861
    [No Abstract]   [Full Text] [Related]  

  • 42. Biochemical balance and syncronized cell cultures.
    Anderson EC; Petersen DF; Tobey RA
    Nature; 1967 Sep; 215(5105):1083-4. PubMed ID: 6053436
    [No Abstract]   [Full Text] [Related]  

  • 43. [Key pericyclic reactions in biological systems and biomimetic synthesis--an overview].
    Pindur U
    Pharm Unserer Zeit; 1995 Apr; 24(2):73-80. PubMed ID: 7753873
    [No Abstract]   [Full Text] [Related]  

  • 44. Enzyme inhibition in relation to chemotherapy.
    ACKERMANN WW; POTTER VR
    Proc Soc Exp Biol Med; 1949 Oct; 72(1):1-9. PubMed ID: 15391660
    [No Abstract]   [Full Text] [Related]  

  • 45. Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.
    Schaffner F
    Gastroenterology; 1969 Sep; 57(3):253-5. PubMed ID: 5808484
    [No Abstract]   [Full Text] [Related]  

  • 46. [Changes in the lipid profile in chronic hepatopathies].
    Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
    Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of plasma lipoprotein components assessed by ultracentrifugation in primary biliary cirrhosis and chronic hepatitis.
    Tacikowski T; Milewski B; Dzieniszewski J; Nowicka G; Walewska-Zielecka B
    Med Sci Monit; 2000; 6(2):325-9. PubMed ID: 11208331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How does fenofibrate exert its cholesterol-lowering effect? (author's transl)].
    Wülfert E
    Nouv Presse Med; 1980 Dec; 9(49):3733-6. PubMed ID: 7208339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paradoxical drug reactions and the biochemical analysis of human disease.
    Zakim D
    Gastroenterology; 1969 Sep; 57(3):357-62. PubMed ID: 5808493
    [No Abstract]   [Full Text] [Related]  

  • 50. Biochemical mechanisms of drug action: what does it take for success?
    Swinney DC
    Nat Rev Drug Discov; 2004 Sep; 3(9):801-8. PubMed ID: 15340390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mechanism of carcinogenic action of therapeutic agents].
    Karkos J
    Pol Tyg Lek; 1971 Jun; 26(24):922-5. PubMed ID: 4934778
    [No Abstract]   [Full Text] [Related]  

  • 52. Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs.
    Packard CJ
    Diabetes Nutr Metab; 1999 Oct; 12(5):311-5. PubMed ID: 10741344
    [No Abstract]   [Full Text] [Related]  

  • 53. [Possibilities in the treatment of primary biliary cirrhosis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Jun; 146(23):1245-9. PubMed ID: 15988919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antisense apolipoprotein B therapy: where do we stand?
    Akdim F; Stroes ES; Kastelein JJ
    Curr Opin Lipidol; 2007 Aug; 18(4):397-400. PubMed ID: 17620855
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.